title: Latest options for treatment of bronchiolitis in infants.
abstract: Bronchiolitis is the most frequent pathology associated with lower respiratory tract infection in newborns and young infants. The treatment of bronchiolitis is essentially supportive therapy for respiratory distress, hypoxia and dehydration. To date, no specific antiviral drug is used on a routine basis for the treatment of RSV infections. Currently, the only antiviral drug approved for the infection is ribavirin; however, its use is limited due to adverse side effects and the risks it poses to healthcare providers. Moreover, several drugs have been routinely administered for years in infants with acute RSV bronchiolitis, even if their efficacy is often not confirmed by clinical evidence, and studies on emerging antiviral drugs are still ongoing. In the present paper we review the recent literature about the drugs used during acute bronchiolitis and we summarize the main recommendations of national and international guidelines and the latest options for the treatment of bronchiolitis.
authors.affiliation: a Neonatology and Neonatal Intensive Care Unit, S.Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
authors.forename: Silvia
authors.initials: S
authors.lastname: Vandini
authors.affiliation: a Neonatology and Neonatal Intensive Care Unit, S.Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
authors.forename: Giacomo
authors.initials: G
authors.lastname: Faldella
authors.affiliation: b Pediatrics and Neonatology Unit , Imola Hospital , Imola , Italy.
authors.forename: Marcello
authors.initials: M
authors.lastname: Lanari
keywords: Bronchiolitis; Bronchodilators; Corticosteroids; Epinephrine; Hypertonic saline solution; Infants; Oxygen Therapy; Respiratory Syncytial Virus; Ribavirin